Terms: = Prostate cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Diagnosis
49 results:
1. Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.
Nguyen NJ; Sherman C; van der Kwast TH; Downes MR
Pathol Res Pract; 2024 Feb; 254():155105. PubMed ID: 38218041
[TBL] [Abstract] [Full Text] [Related]
2. Clear cell urothelial carcinoma of bladder: Case report of a rare and aggressive variant with review of literature.
Sahetia KM; Dave VN; Pal M; Menon S
Indian J Cancer; 2023 Oct; 60(4):575-577. PubMed ID: 38145907
[TBL] [Abstract] [Full Text] [Related]
3. Aberrant expression of gata3 in metastatic adenocarcinoma of the prostate: an important pitfall.
Lobo J; Tenace NP; Cañete-Portillo S; Carneiro I; Henrique R; Lucianò R; Harik LR; Magi-Galluzzi C
Histopathology; 2024 Feb; 84(3):507-514. PubMed ID: 37965687
[TBL] [Abstract] [Full Text] [Related]
4. [Clinicopathological Features of Primary Small Cell Neuroendocrine Carcinoma of the Bladder].
Gu YM; Liang XL; Zhang YG; Zhao HY; Jin ML; Li X; Lu J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Jun; 45(3):429-435. PubMed ID: 37407530
[TBL] [Abstract] [Full Text] [Related]
5. Utility of GATA-3 and associated immunohistochemical markers in the differential diagnosis of poorly differentiated urothelial carcinoma.
Naik M; Rao BV; Challa S; Fonseca D; Sudha SM; Giridhar A; Sharma R; Raju KVVN; Rao TS
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147963
[TBL] [Abstract] [Full Text] [Related]
6. Urothelial carcinoma metastases impacting the CNS: A 20-year retrospective series.
Guzman SJ; Kleinschmidt-DeMasters BK
Ann Diagn Pathol; 2023 Jun; 64():152109. PubMed ID: 36822051
[TBL] [Abstract] [Full Text] [Related]
7. Well-differentiated neuroendocrine tumor of the urinary bladder expressing GATA 3.
Marletta S; Martignoni G; Ghimenton C; Stefanizzi L; Marcolini L; Caliò A
Virchows Arch; 2023 Apr; 482(4):783-788. PubMed ID: 36543974
[TBL] [Abstract] [Full Text] [Related]
8. Efficacy and toxicity following salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after radiotherapy.
Kissel M; Pounou A; Ka K; Alexis A; Irani J; Jereczek-Fossa BA; Terlizzi M; Bossi A; Blanchard P
Brachytherapy; 2022; 21(4):424-434. PubMed ID: 35331666
[TBL] [Abstract] [Full Text] [Related]
9. Left supraclavicular (Virchow's) node metastasis detected before primary infradiaphragmatic tumor: a case series.
Mochizuki Y; Tsuchiya M; Oyama J; Wada A; Kugimoto T; Kuroshima T; Hirai H; Tomioka H; Harada H; Ikeda T; Akashi T
J Med Case Rep; 2022 Jan; 16(1):33. PubMed ID: 35078521
[TBL] [Abstract] [Full Text] [Related]
10. Somatic-Type Yolk Sac Tumor Arising as a Predominant Component of Bladder Urothelial Carcinoma.
Collins K; Alkashash AM; Hwang M; Kaimakliotis HZ; Cheng L; Idrees MT
Int J Surg Pathol; 2022 Apr; 30(2):207-213. PubMed ID: 34255554
[TBL] [Abstract] [Full Text] [Related]
11. Expression of uroplakin II and GATA-3 in bladder cancer mimickers: caveats in the use of a limited panel to determine cell of origin in bladder lesions.
Leivo MZ; Tacha DE; Hansel DE
Hum Pathol; 2021 Jul; 113():28-33. PubMed ID: 33887302
[TBL] [Abstract] [Full Text] [Related]
12. Impact of High-Dose-Rate and Low-Dose-Rate Brachytherapy Boost on Toxicity, Functional and cancer Outcomes in Patients Receiving External Beam Radiation Therapy for prostate cancer: A National Population-Based Study.
Parry MG; Nossiter J; Sujenthiran A; Cowling TE; Patel RN; Morris M; Berry B; Cathcart P; Clarke NW; Payne H; van der Meulen J; Aggarwal A
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1219-1229. PubMed ID: 33279595
[TBL] [Abstract] [Full Text] [Related]
13. Aberrant gata3 Staining in Prostatic Adenocarcinoma: A Potential Diagnostic Pitfall.
McDonald TM; Epstein JI
Am J Surg Pathol; 2021 Mar; 45(3):341-346. PubMed ID: 32769430
[TBL] [Abstract] [Full Text] [Related]
14. Malignant solitary fibrous tumour of the prostate: four cases emphasising significant histological and immunophenotypical overlap with sarcomatoid carcinoma.
Bakhshwin A; Berry RS; Cox RM; Li R; Reynolds JP; Rubin BP; McKenney JK
Pathology; 2020 Oct; 52(6):643-648. PubMed ID: 32758370
[TBL] [Abstract] [Full Text] [Related]
15. Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysis.
Yuan Z; Fernandez D; Dhillon J; Abraham-Miranda J; Awasthi S; Kim Y; Zhang J; Jain R; Serna A; Pow-Sang JM; Poch M; Li R; Manley B; Fink A; Naghavi A; Torres-Roca JF; Grass GD; Kim S; Latifi K; Hunt D; Johnstone PAS; Yamoah K
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):140-149. PubMed ID: 32651467
[TBL] [Abstract] [Full Text] [Related]
16. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
Chan E; Garg K; Stohr BA
Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185
[TBL] [Abstract] [Full Text] [Related]
17. Clinical and pathological characteristics of bladder cancer in post brachytherapy patients.
Au S; Keyes M; Black P; Villamil CF; Tavassoli P
Pathol Res Pract; 2020 Mar; 216(3):152822. PubMed ID: 31982182
[TBL] [Abstract] [Full Text] [Related]
18. Primary yolk sac tumour of the prostate mimicking small round blue cell tumour.
Gui H; Kolster RA; Palmer MB; Brooks JS; Zhang M; Husson MA
Curr Oncol; 2019 Oct; 26(5):e707. PubMed ID: 31708666
[TBL] [Abstract] [Full Text] [Related]
19. High-grade Adenocarcinoma of the prostate Mimicking Urothelial Carcinoma is Negative for TERT Mutations.
Alaghehbandan R; Vanecek T; Trpkov K; Comperat E; Kristiansen G; Svajdler M; Cempirkova D; Pavlovsky M; Pivovarcikova K; Stehlikova A; Hora M; Michal M; Hes O
Appl Immunohistochem Mol Morphol; 2019 Aug; 27(7):523-528. PubMed ID: 31393284
[TBL] [Abstract] [Full Text] [Related]
20. Extramammary Paget Disease of the Scrotum: A Contemporary Clinicopathologic Analysis of 20 Cases in the United States.
Shabihkhani M; Patil P; Murati Amador B; Plaza JA; Osunkoya AO; Lombardo KA; Epstein JI; Matoso A
Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):524-531. PubMed ID: 31290785
[TBL] [Abstract] [Full Text] [Related]
[Next]
